CONSTELLA is the first and only Health Canada-approved prescription therapy for functional constipation in this patient population Submission is based on positive Phase 3 study data demonstrating linaclotide (72mcg) resulted… Read More
By Amy Chen RICHMOND, BC – The British Columbia Institute of Technology (BCIT) and the Canadian Alliance for Skills and Training in Life Sciences (CASTL), in partnership with the Province of BC and… Read More
VANCOUVER, BC – Sonic Incytes Medical Corp, a leader in point-of-care ultrasound, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Velacur® Determined… Read More
Extending GenVoy-ILM product line to accelerate mRNA and saRNA vaccine development GMP-compatible lipids ensure scalability for large-scale manufacturing Cytiva introduces its latest innovation, the RNA delivery LNP kit, specifically designed… Read More
Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA – Moderna, Inc. (Nasdaq:MRNA) announced that its manufacturing facility in Laval, Quebec, has been granted… Read More
